Literature DB >> 12041974

An audit of the tetanus immunisation status of plastic surgery trauma and burns patients.

O C S Cassell1, A J Fitton, W A Dickson, M A P Milling.   

Abstract

This study audits the tetanus immunisation management of plastic surgery trauma patients by their referring Accident and Emergency departments, and compares this to nationally published guidelines. We assessed 269 burns and trauma patients, referred from across South Wales, using a questionnaire together with their Accident and Emergency notes or letter. The precise question(s) that had been asked regarding the tetanus immunisation status of the patient, and the immunisation management based on the results of those questions, were recorded. The accurate tetanus immunisation status of the patient was established, the wound was assessed and further management was given as indicated. Only 16 patients had been asked whether they had received a course of tetanus, and 41 patients were not questioned about their tetanus immunisation status by the referring Accident and Emergency department. As a consequence of more accurate questioning, 73 patients (27%) required further action after their arrival in the Plastic Surgery unit. This audit has demonstrated that the management of tetanus immunoprophylaxis in plastic surgery trauma patients cannot be confidently left to the referring Accident and Emergency department but should form an integral part of the treatment at the admitting unit. Copyright 2002 The British Association of Plastic Surgeons.

Entities:  

Mesh:

Year:  2002        PMID: 12041974     DOI: 10.1054/bjps.2001.3742

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  2 in total

1.  Death from tetanus after a pretibial laceration.

Authors:  Oliver C S Cassell
Journal:  BMJ       Date:  2002-06-15

2.  Determination of Tetanus Antibody Levels in Trauma Patients Referred To Shahid Beheshti Hospital in Kashan, Iran, 2014.

Authors:  Hasan Afzali; Mohammad Reza Sharif; Shamsaddin Mousavi
Journal:  Arch Trauma Res       Date:  2015-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.